The occurrence of this phenomenon in cancer disease may lead to the escape of tumor cells from immune surveillance (12), and the increased concentration of IL-10 in the serum of cancer patients is correlated with an unfavorable prognosis (13–15). This evidence concerns the gene IL10 and neoplasm.